Navigation Links
Cell Therapeutics, Inc. (CTI) to Present at 7th Annual WBBA Invest Northwest Conference
Date:3/9/2008

SEATTLE, March 10 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTAX) management will present at the 7th Annual WBBA Invest Northwest Conference on Tuesday, March 18th at 9:00 AM in the Bay Auditorium of the Bell Harbor Conference Center.

The presentation will also be webcast live with slides, and available for replay after the presentation. The webcast can be accessed at http://www.cticseattle.com.

WBBA Invest Northwest Conference

CTI Presentation: Tuesday, March 18, 2008

9:00 AM PDT/12:00 PM EDT/5:00 PM CET

Bay Auditorium, Bell Harbor Conference Center

Audio webcast with slides at http://www.cticseattle.com

Media Contact:

Cell Therapeutics, Inc.

Dan Eramian

T: 206.272.4343

F: 206.272.4434

E: media@ctiseattle.com

http://www.cticseattle.com/media.htm

Investors Contact:

Cell Therapeutics, Inc.

Leah Grant

T: 206.272.4345

F: 206.272.4434

E: invest@ctiseattle.com

http://www.cticseattle.com/investors.htm


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End Financial Results on March 13
2. Cell Therapeutics, Inc. to Hold Conference Call to Update on Recent Transactions and Upcoming Milestones
3. M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
4. Cell Therapeutics, Inc. (CTI) Announces Cancellation of Approximately $9.1 Million of Existing Notes due 2008
5. Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
6. Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008
7. Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO CEO & Investor Conference
8. Nile Therapeutics, Inc. to Present at Upcoming BIO CEO & Investor Conference
9. Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
10. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
11. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...o also Visit Detroit , (V...French Ambassador for International Investment, an... , , , ,What: Ambassador Appia is available to me...atives adopted by France to further develop the fi...ion and development., , ,When: Available for Inter...
(Date:11/24/2009)...RNewswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq:...heNasdaqStockMarketthattradinginthecompany,scommon...-NSEwillbefiledwiththe,SecuritiesandExchangeCommis...gonNasdaq,unlessthecompanyfilesanappealtotheNasdaq...anappeal,which,willstaythesuspensionanddelistingth...
(Date:11/24/2009)...a/--NODPharmaceuticalsInc.announced,theUSPatent&am...onfor,itsnano-particleoraldeliveryorNODtechnology....ncorporatepeptidesor,proteinsintobio-adhesivenano-...nisteredasinjections.NODtechnologyisaplatformtechn...hasinsulin,interferon,growthhormone,exenatide,hep...
(Date:11/24/2009)...ntly approved the Promega PowerPlex 16 HS System f...ing DNA records for the National DNA Index System....) -- The FBI recently approved the Promega PowerP...ticipating in, or generating DNA records for, the ...ontains more than seven million profiles and has a...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
... Researchers from industry and academia have submi...n in seed grants offered by John and Tashia Morgri...rsity of Wisconsin-Madison schools and colleges, ...ties around the world. Successful applicants will ... due by Oct. 1, and the seed grants will be awarde...
... The Wisconsin Alumni Research Foundation has fi...Biosciences to develop new research tools for emb..., ,As part of the agreement, BD Biosciences, a div... & Co ., has agreed to a non-exclusive license to ...o commercial and academic laboratories. In develop...
...the midpoint of 2006 already. The first half stock...t 4%. Two months ago, the Dow was up twice that le...ne and beginning to bounce back in July. The NASDA...having dropped 2%. , ,We all know about continued ...gallon level. This time, surprisingly, American co...
Other Biology Technology:Morgridge seed grants attract over 220 proposals 2WARF signs licensing pact with BD Biosciences 2First half of 2006 roundup: Big Pharma trumps biotech 2First half of 2006 roundup: Big Pharma trumps biotech 3First half of 2006 roundup: Big Pharma trumps biotech 4First half of 2006 roundup: Big Pharma trumps biotech 5First half of 2006 roundup: Big Pharma trumps biotech 6
(Date:11/24/2009)..., This release is available in Spanish . ,...e higher levels of inflammatory substances in the ...ight; as shown by a research project of the Univer...oto, a scientist at the School of Pharmacy. , Th...ic study in relation to the control of body weight...
(Date:11/23/2009)..., , Cambridge, Mass. November 23, 2009 Applie...lantain lily ( Hosta lancifolia ), a characteristi...closely packed ripples along the edges. The simple...ion resulting from bending during differential gro...ue, stretching foam ribbons. , Haiyi Liang, a po...
(Date:11/23/2009)..., IRVINE, Calif. -- More than 160 participants ga...cademies Keck FUTURES INITIATIVE conference. This ...r scientists, engineers, and medical researchers t...issues surrounding the emerging field of synthetic...cular biology at Princeton University and this yea...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Brain power goes green 10349 1SIMNSA is added to the Satori Global Network 26amp 3B 238482 3B in Mexico to Offer U S Employers Cross Border Health Benefit Options 59446 1SIMNSA is added to the Satori Global Network 26amp 3B 238482 3B in Mexico to Offer U S Employers Cross Border Health Benefit Options 59446 2Toms of Maine and charity 3A water Team Up to Fund Global Clean Water Projects With Instant Mobile Donation Campaign 59444 1Toms of Maine and charity 3A water Team Up to Fund Global Clean Water Projects With Instant Mobile Donation Campaign 59444 2Toms of Maine and charity 3A water Team Up to Fund Global Clean Water Projects With Instant Mobile Donation Campaign 59444 3
...study by Ohio State University cancer researchers ... miR-29b in acute myeloid leukemia (AML) cells can...mature, fast growing state of development. , The... genes, which enables the leukemic cells to differ...heir death. The findings suggest that miR-29b coul...
...on University in St. Louis have figured out the or...ts neighboring membrane in a photosynthetic bacter...in photosynthesis. , Robert Blankenship, Ph.D., M...stry in Arts & Sciences, led a team that for the f...ctroscopy to verify the orientation. The team also...
...es Darwin, researchers are interested in reconstru... development of animal and plant species during th...es, this research has already come quite a long wa...onships between the animal groups that made their ...bably in the late Precambrian, some 650� mi...
Other Biology News:A miR boost enables acute leukemia cells to mature 2Orientation of antenna protein in photosynthetic bacteria described 2Orientation of antenna protein in photosynthetic bacteria described 3Early family ties: No sponge in the human family tree 2Early family ties: No sponge in the human family tree 3
Mouse Anti-Bovine Complex IV Monoclonal Antibody, Unconjugated, Clone 31E91B82G9 from MitoScience LLC
Rabbit Anti-gp120/160(SIV/mac239) Polyclonal Antibody, Unconjugated from Immune Technology
Rabbit Anti-GPCR TM7XN1 Polyclonal Antibody, Unconjugated from Abcam
Annexin V Binding Buffer from BD Biosciences Pharmingen
Biology Products: